Zai Lab's October return shows stable shares, active equity incentives

Zai Lab Limited's monthly return for October 2025 indicates a stable issued share capital with 1,117,628,030 ordinary shares. Out of these, 367,016,100 ordinary shares are held as American Depositary Shares. The total authorized/registered share capital remains at 5,000,000,000 ordinary shares with a par value of $0.000006, totaling $30,000. There were no new shares issued or treasury shares transferred during the month.

Movements within equity incentive plans show activity across various schemes. The 2017 Equity Incentive Plan saw 357,880 lapsed options, while the 2022 Equity Incentive Plan had 18,630 lapsed options. A grant of 250,000 options occurred under the 2024 Equity Incentive Plan, increasing its outstanding options to 7,546,290.

The report also detailed vesting and lapsing of Restricted Share Unit Awards (RSUs) and Performance-based Restricted Share Unit Awards (PSUs). Under the 2017 plan, 32,810 RSUs and 26,210 RSUs lapsed. The 2022 plan had 11,900 RSUs vest and 21,880 RSUs lapse. For the 2024 plan, 321,500 RSUs were granted, 58,000 RSUs vested, and 14,250 RSUs lapsed.